Global Cord Blood Corporation – NYSE:CO

Add to watchlist

$2.988

Market closed

Open in 3 days

+0.01%

month

+0.01%

quarter

+26.08%

year

Market Cap	400.08M
Enterprise value	N/A

P/E	5.06
EV/Sales	-5.06
EV/EBITDA	-10.02
Price/Sales	1.91
Price/Book	0.48
PEG ratio	-3.58
EPS	4.13

Revenue	1.24B
EBITDA	637.79M
Income	502.43M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	40.3%
Oper. margin	48.97%
Gross margin	85.26%
EBIT margin	48.97%
EBITDA margin	51.3%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Global Cord Blood Corporation (NYSE:CO): Profit margin
Jun 2021	315.17M	136.42M	43.28%
Sep 2021	313.67M	125.73M	40.09%
Dec 2021	317.20M	135.55M	42.74%
Mar 2022	297.20M	104.71M	35.23%

Global Cord Blood Corporation (NYSE:CO): Payout ratio
Payout ratio	0%

Global Cord Blood Corporation (NYSE:CO): Dividend Yield
2013
2017
2019	0.3%
2020
2022

Global Cord Blood Corporation (NYSE:CO): Debt to assets
Sep 2021	8258258000	3.60B	43.65%
Dec 2021	8397726000	3.61B	42.99%
Mar 2022	8534525000	3.64B	42.76%
Jul 2022	1346288000	575.70M	42.76%

Global Cord Blood Corporation (NYSE:CO): Cash Flow
Jun 2011	0	0
Sep 2011	0	0
Dec 2011	0	0
Mar 2022	162.03M	-6.25M

Global Cord Blood alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Global Cord Blood
Employees

Global Cord Blood Corporation (NYSE:CO): Employee count
Aug 2023	1,202
Sep 2023	1,202
Oct 2023	1,202
Nov 2023	1,202
Dec 2023	1,202
Jan 2024	1,202
Feb 2024	1,202
Mar 2024	1,202
Apr 2024	1,202
May 2024	1,202
Jun 2024	1,202
Jul 2024	1,202

Global Cord Blood
Hedge Funds Holdings Q3 2022

10.66% +1.02%

of CO is owned by hedge funds

22 -3

hedge funds hold CO stock

12.96M +1.23M

shares is hold by hedge funds

CO hedge funds holdings changes

Global Cord Blood
Insider Trading

Global Cord Blood Corporation (NYSE:CO): Insider trades (number of shares)
Period	Buy	Sel
May 2014	109000	0
Jun 2014	127000	0
Jul 2014	50000	0
Sep 2014	43705	0
Nov 2014	266754	0
Dec 2014	730000	0
Jan 2015	310000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	21 Jan 2015	MCCARTHY KENT C 10 percent owner, other: 13 (d) group owni.. 10 percent owner, other: 13 (d)..	Common Stock	20,000	$4.6	$92,020
Purchase	21 Jan 2015	JAYHAWK PRIVATE EQUITY FUND II LP other: 13 (d) group owni.. other: 13 (d) group owning > 10%	Common Stock	20,000	$4.6	$92,020
Purchase	16 Jan 2015	MCCARTHY KENT C 10 percent owner, other: 13 (d) group owni.. 10 percent owner, other: 13 (d)..	Common Stock	50,000	$4.3	$215,000
Purchase	16 Jan 2015	JAYHAWK PRIVATE EQUITY FUND II LP other: 13 (d) group owni.. other: 13 (d) group owning > 10%	Common Stock	50,000	$4.3	$215,000
Purchase	14 Jan 2015	JAYHAWK PRIVATE EQUITY FUND II LP other: 13 (d) group owni.. other: 13 (d) group owning > 10%	Common Stock	10,000	$4.52	$45,170
Purchase	14 Jan 2015	MCCARTHY KENT C 10 percent owner, other: 13 (d) group owni.. 10 percent owner, other: 13 (d)..	Common Stock	10,000	$4.52	$45,170
Purchase	12 Jan 2015	JAYHAWK PRIVATE EQUITY FUND II LP other: 13 (d) group owni.. other: 13 (d) group owning > 10%	Common Stock	50,000	$4.69	$234,400
Purchase	12 Jan 2015	MCCARTHY KENT C 10 percent owner, other: 13 (d) group owni.. 10 percent owner, other: 13 (d)..	Common Stock	50,000	$4.69	$234,400
Purchase	2 Jan 2015	MCCARTHY KENT C 10 percent owner, other: 13 (d) group owni.. 10 percent owner, other: 13 (d)..	Common Stock	25,000	$4.62	$115,425
Purchase	2 Jan 2015	JAYHAWK PRIVATE EQUITY FUND II LP other: 13 (d) group owni.. other: 13 (d) group owning > 10%	Common Stock	25,000	$4.62	$115,425

CO insider trading transactions

Global Cord Blood
Earnings Call Transcripts

Quarter	Transcript
Q3 2022 1 Mar 2022	Q3 2022 Earnings Call Transcript
Q2 2022 26 Nov 2021	Q2 2022 Earnings Call Transcript
Q4 2021 29 Jun 2021	Q4 2021 Earnings Call Transcript
Q2 2021 25 Nov 2020	Q2 2021 Earnings Call Transcript

CO earnings call transcripts

Global Cord Blood
Executives

Insider	Age	Compensation
Mr. Bing Chuen Chen (1976) Chief Financial Officer & Director	49	$516,680
Ms. Ting Zheng (1972) Chairperson , Chief Executive Officer & Chief Executive Officer of Beijing Division	53	$516,680
Ms. Rui Arashiyama (1959) Chief Executive Officer of Guangdong & Zhejiang Divisions	66	$257,500
Ms. Xin Xu (1954) Chief Technology Officer	71	$122,780

Global Cord Blood
Latest News

Monday, 24 June 2024
13:18	CO, CORBF DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF	globenewswire.com
Saturday, 22 June 2024
08:15	CO, CORBF Deadline: CO, CORBF Investors Have the Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit	prnewswire.com
Friday, 21 June 2024
12:15	INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord	globenewswire.com
Thursday, 20 June 2024
19:54	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF	globenewswire.com
Sunday, 16 June 2024
16:47	ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF	globenewswire.com
Friday, 14 June 2024
10:00	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)	globenewswire.com
Thursday, 13 June 2024
10:38	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF	globenewswire.com
Wednesday, 12 June 2024
18:04	ROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF	globenewswire.com
11:25	INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord	globenewswire.com
Tuesday, 11 June 2024
17:26	Rosen Law Firm Urges Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) Stockholders With Large Losses to Contact the Firm for Information About Their Rights	businesswire.com
11:56	Global Cord Blood Corporation Investors: Looming Deadline in Class action lawsuit filed on behalf of investors; the Portnoy Law Firm	globenewswire.com
Monday, 10 June 2024
16:00	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF	prnewswire.com
Friday, 7 June 2024
17:05	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF	globenewswire.com
15:38	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)	globenewswire.com
Thursday, 6 June 2024
11:20	SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord	prnewswire.com
Wednesday, 5 June 2024
14:39	CORBF STOCKHOLDERS: Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Global Cord Blood Corporation Class Action	globenewswire.com
12:15	DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord	globenewswire.com
10:12	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF	globenewswire.com
Monday, 3 June 2024
18:09	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF	globenewswire.com
15:55	Hach Rose Schirripa & Cheverie, LLP Announce Investigation Into Global Cord Blood Corp.	prnewswire.com
11:11	Kirby McInerney LLP Reminds Global Cord Blood Corporation (CORBF) Investors of Upcoming Deadline in Class Action Filing	globenewswire.com
Friday, 31 May 2024
11:20	DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord	prnewswire.com
Thursday, 30 May 2024
15:55	ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF	prnewswire.com
Monday, 20 May 2024
20:30	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF	prnewswire.com
Monday, 13 May 2024
15:14	ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF	prnewswire.com
Tuesday, 7 May 2024
18:03	CO Stockholders with Significant Losses Should Contact Robbins LLP for Information About the Global Cord Blood Corporation Securities Class Action	businesswire.com
Monday, 6 May 2024
20:45	ROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF	prnewswire.com
Friday, 3 May 2024
12:45	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord	prnewswire.com
Friday, 26 April 2024
19:06	ROSEN, A RANKED AND LEADING FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF	prnewswire.com
15:25	Global Cord Blood Corporation (CO) Investor Notice: Robbins LLP Reminds Stockholders of the Global Cord Blood Corporation Class Action	businesswire.com

Frequently Asked Questions (FAQ)

What's the price of Global Cord Blood stock today?

One share of Global Cord Blood stock can currently be purchased for approximately $2.99.
When is Global Cord Blood's next earnings date?

Unfortunately, Global Cord Blood's (CO) next earnings date is currently unknown.
Does Global Cord Blood pay dividends?

No, Global Cord Blood does not pay dividends.
How much money does Global Cord Blood make?

Global Cord Blood has a market capitalization of 400.08M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.21% to 1.24B US dollars.
What is Global Cord Blood's stock symbol?

Global Cord Blood Corporation is traded on the NYSE under the ticker symbol "CO".
What is Global Cord Blood's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of Global Cord Blood?

Shares of Global Cord Blood can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Global Cord Blood's key executives?
Global Cord Blood's management team includes the following people:
- Mr. Bing Chuen Chen Chief Financial Officer & Director(age: 49, pay: $516,680)
- Ms. Ting Zheng Chairperson , Chief Executive Officer & Chief Executive Officer of Beijing Division(age: 53, pay: $516,680)
- Ms. Rui Arashiyama Chief Executive Officer of Guangdong & Zhejiang Divisions(age: 66, pay: $257,500)
- Ms. Xin Xu Chief Technology Officer(age: 71, pay: $122,780)
How many employees does Global Cord Blood have?

As Jul 2024, Global Cord Blood employs 1,202 workers.
When Global Cord Blood went public?

Global Cord Blood Corporation is publicly traded company for more then 18 years since IPO on 25 Jan 2007.
What is Global Cord Blood's official website?

The official website for Global Cord Blood is globalcordbloodcorp.com.
How can i contact Global Cord Blood?

Global Cord Blood can be reached via phone at +852 3605 8180.

Global Cord Blood Corporation

globalcordbloodcorp.com

Exchange:

NYSE

Full time employees:

1,202

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

+852 3605 8180

Bank of China Tower
Central,

CIK: 0001467808
ISIN: KYG393421030
CUSIP: G39342103